Gong Fengrong, Xin Shuzi, Liu Xiaohui, He Chengwei, Yu Xinyi, Pan Luming, Zhang Sitian, Gao Han, Xu Jingdong
Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Front Microbiol. 2024 Aug 19;15:1445630. doi: 10.3389/fmicb.2024.1445630. eCollection 2024.
The gut microbiota is vital to human health, and their biofilms significantly impact intestinal immunity and the maintenance of microbial balance. Certain pathogens, however, can employ biofilms to elude identification by the immune system and medical therapy, resulting in intestinal diseases. The biofilm is formed by extracellular polymorphic substances (EPS), which shield microbial pathogens from the host immune system and enhance its antimicrobial resistance. Therefore, investigating the impact of extracellular polysaccharides released by pathogens that form biofilms on virulence and defence mechanisms is crucial. In this review, we provide a comprehensive overview of current pathogenic biofilm research, deal with the role of extracellular polymers in the formation and maintenance of pathogenic biofilm, and elaborate different prevention and treatment strategies to provide an innovative approach to the treatment of intestinal pathogen-based diseases.
肠道微生物群对人类健康至关重要,其生物膜对肠道免疫和微生物平衡的维持有显著影响。然而,某些病原体可利用生物膜逃避免疫系统的识别和医学治疗,从而导致肠道疾病。生物膜由细胞外多态性物质(EPS)形成,这些物质可保护微生物病原体免受宿主免疫系统的攻击,并增强其抗微生物耐药性。因此,研究形成生物膜的病原体释放的细胞外多糖对毒力和防御机制的影响至关重要。在本综述中,我们全面概述了当前致病性生物膜的研究,探讨了细胞外聚合物在致病性生物膜形成和维持中的作用,并阐述了不同的预防和治疗策略,以为基于肠道病原体的疾病治疗提供创新方法。